Miguel Melo - Concepedia

Author

Miguel Melo

Also Known As

M Melo, M. Melo, M.M. Melo, MARCIA DA SILVA MELO, Manuella Nogueira Borges de Melo, Mara Rebeca de O. P. de M. Melo, Marcela Gomes de Miranda Brito Monteiro Vera Cruz Feijó de Melo, Maria Claudia Costa Américo de Melo, Maria Cláudia Alheiros Lira de Melo, Maria Eduarda Medeiros De Melo

147

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

University of Coimbra Universidade do Porto Hospitais da Universidade de Coimbra Hospital de São João i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto

About

Miguel Melo is an author at University of Coimbra specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	966
2	Endocrinology	2	2	33
3	Health Sciences	1	1	16
4	General Internal Medicine	1	1	20
5	Hospital Medicine	1	1	20

Miguel Melo

Publications

Citations

H-Index

Page 1

	Year	Citations
Frequency of TERT promoter mutations in human cancers João Vinagre, Ana Paula de Almeida, Helena Pópulo, Nature Communications Somatic VariantTert Promoter MutationsPathologyCancer GenomicsCancer Genetics	2013	882
TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas Miguel Melo, Adriana Gaspar da Rocha, João Vinagre, The Journal of Clinical Endocrinology & Metabolism	2014	537
TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease Miguel Melo, Adriana Gaspar da Rocha, Rui Batısta, The Journal of Clinical Endocrinology & Metabolism	2017	139
NIS expression in thyroid tumors, relation with prognosis clinicopathological and molecular features Catarina Tavares, Maria João Coelho, Catarina Eloy, Endocrine Connections	2018	71
Clinicopathological Features as Prognostic Predictors of Poor Outcome in Papillary Thyroid Carcinoma Antónia Povoa, Elisabete Teixeira, María Rosa Bella, Cancers	2020	45
Stimulated Thyroglobulin at Recombinant Human TSH-Aided Ablation Predicts Disease-free Status One Year Later Miguel Melo, Gracinda Costa, Cristina Ribeiro, The Journal of Clinical Endocrinology & Metabolism	2013	40
Polymorphisms in the TNFA and IL6 Genes Represent Risk Factors for Autoimmune Thyroid Disease Cecília Durães, Carla Susete Leal Moreira, Inês Alvelos, PLoS ONE	2014	37
mTOR Pathway in Papillary Thyroid Carcinoma: Different Contributions of mTORC1 and mTORC2 Complexes for Tumor Behavior and SLC5A5 mRNA Expression Catarina Tavares, Catarina Eloy, Miguel Melo, International Journal of Molecular Sciences	2018	37
Genetic Determinants for Prediction of Outcome of Patients with Papillary Thyroid Carcinoma Antónia Povoa, Elisabete Teixeira, María Rosa Bella, Cancers	2021	34
The diseases we cause: Iatrogenic illness in a department of internal medicine S Gamboa Madeira, Miguel Melo, Joao G. Porto, European Journal of Internal Medicine Disease DiagnosisChronic DiseaseClinical EpidemiologyDiagnosisPatient Safety	2007	20

Page 1